These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 7139866

  • 1. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.
    Gupta RC, Reddy MV, Randerath K.
    Carcinogenesis; 1982; 3(9):1081-92. PubMed ID: 7139866
    [Abstract] [Full Text] [Related]

  • 2. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
    Reddy MV, Gupta RC, Randerath E, Randerath K.
    Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
    [Abstract] [Full Text] [Related]

  • 3. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV, Randerath K.
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [Abstract] [Full Text] [Related]

  • 4. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
    Vulimiri SV, Smith CV, Randerath E, Randerath K.
    Carcinogenesis; 1994 Sep; 15(9):2061-4. PubMed ID: 7923604
    [Abstract] [Full Text] [Related]

  • 5. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [Abstract] [Full Text] [Related]

  • 6. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K, Randerath E, Danna TF, van Golen L, Putman KL.
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [Abstract] [Full Text] [Related]

  • 7. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K, Liehr JG, Gladek A, Randerath E.
    IARC Sci Publ; 1989 Jul; (96):189-205. PubMed ID: 2509347
    [Abstract] [Full Text] [Related]

  • 8. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
    Gupta RC, Earley K.
    Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
    [Abstract] [Full Text] [Related]

  • 9. Postlabeling methods for carcinogen-DNA adduct analysis.
    Randerath K, Randerath E, Agrawal HP, Gupta RC, Schurdak ME, Reddy MV.
    Environ Health Perspect; 1985 Oct; 62():57-65. PubMed ID: 3910421
    [Abstract] [Full Text] [Related]

  • 10. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV, Randerath K.
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [Abstract] [Full Text] [Related]

  • 11. Nuclease S1-mediated enhancement of the 32P-postlabeling assay for aromatic carcinogen-DNA adducts.
    Reddy MV.
    Carcinogenesis; 1991 Sep; 12(9):1745-8. PubMed ID: 1893535
    [Abstract] [Full Text] [Related]

  • 12. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
    Reddy MV, Irvin TR, Randerath K.
    Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
    [Abstract] [Full Text] [Related]

  • 13. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN, Weber WW.
    Anal Biochem; 1988 Nov 01; 174(2):381-92. PubMed ID: 3239743
    [Abstract] [Full Text] [Related]

  • 14. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ, Wogan GN.
    Carcinogenesis; 1989 Sep 01; 10(9):1567-77. PubMed ID: 2670301
    [Abstract] [Full Text] [Related]

  • 15. C18 thin-layer chromatographic enhancement of the 32P-postlabeling assay for aromatic or bulky carcinogen-DNA adducts: evaluation of adduct recoveries in comparison with nuclease P1 and butanol methods.
    Reddy MV.
    J Chromatogr; 1993 May 05; 614(2):245-51. PubMed ID: 8314936
    [Abstract] [Full Text] [Related]

  • 16. High-resolution anion-exchange and partition thin-layer chromatography for complex mixtures of 32P-postlabeled DNA adducts.
    Spencer-Beach GG, Beach AC, Gupta RC.
    J Chromatogr B Biomed Appl; 1996 Mar 03; 677(2):265-73. PubMed ID: 8704930
    [Abstract] [Full Text] [Related]

  • 17. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
    Reddy MV, Bleicher WT, Blackburn GR, Mackerer CR.
    Carcinogenesis; 1990 Aug 03; 11(8):1349-57. PubMed ID: 2387021
    [Abstract] [Full Text] [Related]

  • 18. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N, Padgett WT, Nelson GB, Lambert GR, Ross JA, Nesnow S.
    Anal Biochem; 2006 Aug 15; 355(2):213-23. PubMed ID: 16797471
    [Abstract] [Full Text] [Related]

  • 19. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV.
    IARC Sci Publ; 1993 Aug 15; (124):25-34. PubMed ID: 8225492
    [Abstract] [Full Text] [Related]

  • 20. 32P-postlabeling and HPLC separation of DNA adducts formed by diesel exhaust extracts in vitro and in mouse skin and lung after topical treatment.
    Savela K, King L, Gallagher J, Lewtas J.
    Carcinogenesis; 1995 Sep 15; 16(9):2083-9. PubMed ID: 7554058
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.